Histone Deacetylase Inhibitors Sensitize TRAIL-Induced Apoptosis in Colon Cancer Cells

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is considered as a promising anti-cancer therapeutic. However, many cancers have been found to be or to become inherently resistant to TRAIL. A combination of epigenetic modifiers, such as histone deacetylase inhibitors (HDACi’s), with...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Baojie, Liu, Bin, Chen, Deng, Setroikromo, Rita, Haisma, Hidde J., Quax, Wim J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562715/
https://www.ncbi.nlm.nih.gov/pubmed/31083396
http://dx.doi.org/10.3390/cancers11050645

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562715/
https://www.ncbi.nlm.nih.gov/pubmed/31083396
http://dx.doi.org/10.3390/cancers11050645

Ejemplares similares